Ruth Langley
Prof. Ruth Langley is a prominent researcher at University College London, currently leading the Add-Aspirin trial, which investigates the potential of aspirin in preventing the recurrence of early-stage cancers.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
United Kingdom:
Prof Ruth Langley, from the MRC Clinical Trials Unit at University College London, is leading the Add-Aspirin trial to see if aspirin can stop early stage cancers from coming back.
8
India:
Prof Ruth Langley at University College London is leading a trial called Add-Aspirin to explore whether aspirin can prevent early-stage cancers from returning.
8